Any current/future new fundraising through debt or equity?

There is no specific mention of current or planned new fundraising through debt or equity in the provided transcript. The company completed a capital raise in FY '25, which supports ongoing investments and growth. Investments and expansions, such as the Sharjah facility, are being funded by this existing capital. Management expects to achieve targeted ROCE (~20%) following the completion of current investments by FY '27. No explicit plans for additional debt or equity issuance were discussed during the call.

Any current/future capex/capital investment/strategic investment?

**Sharjah Facility Expansion:** Currently at architectural stage; tender expected in July 2025; operational by July 2026. **Capex Focus:** Investments ongoing in Sharjah plant through FY '26 and partly in FY '27. **ROCE Target:** Aim to achieve ~20% ROCE post-completion of these capital investments. **Strategic Growth:** Expansion supports accelerated growth path to match peer performance levels. **R&D Investment:** Continued focus on in-house technology development with 9 patents awarded and 21 applications filed as of March 2025. **Emerging Technologies:** Investment in developing solutions

Future growth expectations in sales/revenue/volumes?

FY '25 revenue was ₹594.44 crore, up 19.64% YoY. Expect strong growth of 18%-20% annually driven by water security and sustainability demand. Product business (membrane sales) targets ₹30 crore in FY '26 and ₹85 crore over next few years, up from ₹7.8 crore. O&M business expected to grow ~20% with capacity additions and third-party contracts. Order pipeline around ₹2,000 crore with 30% conversion expected this year. Expansion at Sharjah facility to be operational by July 2026, supporting international growth. Entry into new sectors like solar PV, green hydrogen, carbon capture, and semiconduct

Future growth expectations in earnings/operating earnings/profits/EPS?

Expect strong growth in FY '26 supported by a healthy order book of Rs. 5,327 million as of March 31, 2025. Revenue growth guidance around 18% to 20% annually driven by domestic and international demand. Operational leverage anticipated to improve EBITDA margins, expected to remain healthy. O&M business projected to grow at approximately 20%, faster due to capacity additions and third-party contract traction. Product membrane segment targets significant scaling: from Rs. 7.8 crore in FY '25 to Rs. 30 crore in FY '26 and Rs. 85 crore in next few years. ROCE target is to reach around 20% post co

Current/ Expected Orderbook/ Pending Orders?

As of March 31, the order book stood at Rs. 5,327 million (~Rs. 532.7 crore). The total pipeline of quotations under discussion is roughly Rs. 2,000 crore (exactly about Rs. 1,900 crore). Of this pipeline, "hot orders" with substantial closure and winning possibility are about Rs. 400 crore. The company expects to convert about 30% of the Rs. 2,000 crore pipeline into actual orders in the fiscal year. Current order book composition: ~62% water projects, 15% compressed biogas (CBG), and 23% O&M. Execution cycles: Water projects typically 12-18 months, CBG projects around 14 months. Order book s

IN US

Sale is live|00:00:00left today

Concord Enviro Systems LtdQ1 FY25Other Utilities

Concord Enviro Systems Ltd Q1 FY25 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹355P/E: 10.8Market Cap: ₹600 CrSector: Other Utilities

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

Yes

Order

Yes

Capex

Yes

3 of 5 growth signals are positive.

Full analysis

Revenue guidance

Category 3

→FY '25 revenue was ₹594.44 crore, up 19.64% YoY.
→Expect strong growth of 18%-20% annually driven by water security and sustainability demand.
→Product business (membrane sales) targets ₹30 crore in FY '26 and ₹85 crore over next few years, up from ₹7.8 crore.
→O&M business expected to grow ~20% with capacity additions and third-party contracts.
→Order pipeline around ₹2,000 crore with 30% conversion expected this year.
→Expansion at Sharjah facility to be operational by July 2026, supporting international growth.
→Entry into new sectors like solar PV, green hydrogen, carbon capture, and semiconductors to drive incremental revenues.
→Expansion into U.S. market initiated, expected to accelerate international sales.
→Goal to improve revenue mix with more even quarterly distribution as business scales.

Margin guidance

Category 3

→Expect strong growth in FY '26 supported by a healthy order book of Rs. 5,327 million as of March 31, 2025.
→Revenue growth guidance around 18% to 20% annually driven by domestic and international demand.
→Operational leverage anticipated to improve EBITDA margins, expected to remain healthy.
→O&M business projected to grow at approximately 20%, faster due to capacity additions and third-party contract traction.
→Product membrane segment targets significant scaling: from Rs. 7.8 crore in FY '25 to Rs. 30 crore in FY '26 and Rs. 85 crore in next few years.
→ROCE target is to reach around 20% post completion and revenue ramp-up of new investments by FY '27.
→International expansion, including the Sharjah plant operational by July 2026, will contribute to growth.
→EBITDA expected to grow along with revenue, with 16% YoY growth achieved in FY '25 and further improvements expected.

3 more insights locked — sign up free to unlock

Fundraise plans

Yes

→There is no specific mention of current or planned new fundraising through debt or equity in the provided transcript.
→The company completed a capital raise in FY '25, which supports ongoing investments and growth.
→Investments and expansions, such as the Sharjah facility, are being funded by this existing capital.
→Management expects to achieve targeted ROCE (~20%) following the completion of current investments by FY '27.
→No explicit plans for additional debt or equity issuance were discussed during the call.

Order book

Yes

→As of March 31, the order book stood at Rs. 5,327 million (~Rs. 532.7 crore).
→The total pipeline of quotations under discussion is roughly Rs. 2,000 crore (exactly about Rs. 1,900 crore).
→Of this pipeline, "hot orders" with substantial closure and winning possibility are about Rs. 400 crore.
→The company expects to convert about 30% of the Rs. 2,000 crore pipeline into actual orders in the fiscal year.
→Current order book composition: ~62% water projects, 15% compressed biogas (CBG), and 23% O&M.
→Execution cycles: Water projects typically 12-18 months, CBG projects around 14 months.
→Order book split: Rs. 180 crore from international markets and Rs. 350 crore from domestic markets.

Capex plans

Yes

→**Sharjah Facility Expansion:** Currently at architectural stage; tender expected in July 2025; operational by July 2026.
→**Capex Focus:** Investments ongoing in Sharjah plant through FY '26 and partly in FY '27.
→**ROCE Target:** Aim to achieve ~20% ROCE post-completion of these capital investments.
→**Strategic Growth:** Expansion supports accelerated growth path to match peer performance levels.
→**R&D Investment:** Continued focus on in-house technology development with 9 patents awarded and 21 applications filed as of March 2025.
→**Emerging Technologies:** Investment in developing solutions for solar PV, green hydrogen, carbon capture, semiconductors.
→**IPO Proceeds:** Approximately Rs. 80 crore available post margin money, likely fueling ongoing and future investments.

How does Concord Enviro Systems Ltd rank vs peers in Other Utilities?

Pro feature

1Concord Enviro Systems Ltd

Rev 3Mar 3

See full Other Utilities sector rankings

Want more stocks like Concord Enviro Systems Ltd?

Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.

Build my portfolio